CAS 140926-75-6

Nsc 5844

CAS : 140926-75-6

Formule : C₂₀H₁₆Cl₂N₄

Degré de pureté : 98%

Masse moléculaire : 383.2738

Ref: IN-DA001FMW

RE-640

CAS : 140926-75-6

RE-640

Degré de pureté : ≥98%

Masse moléculaire : 383.27g/mol

Ref: 54-BUP06341

RE-640

CAS : 140926-75-6

NSC-5844 (RE-640) (RE640) is a bisquinoline compound with C-C chemokine receptor type 1 (CCR1)-agonistic activities.

Formule : C₂₀H₁₆Cl₂N₄

Degré de pureté : 99.60% - 99.87%

Couleur et forme : Solid

Masse moléculaire : 383.27

Ref: TM-T3188

NSC 5844

CAS : 140926-75-6

NSC 5844 is a therapeutic inhibitor of angiogenesis. It inhibits the growth of new blood vessels that are required for tumors to grow and spread. NSC 5844 has been shown to inhibit the proliferation of endothelial cells in vitro and in vivo, and this activity is mediated through inhibition of vascular endothelial growth factor (VEGF) receptor tyrosine kinase. This drug also blocks tumor growth in animal models by inhibiting angiogenesis.

Formule : C₂₀H₁₆Cl₂N₄

Degré de pureté : Min. 95%

Masse moléculaire : 383.27 g/mol

Ref: 3D-QFA92675